Connected Health Excellence: Best Practices, LLC Report Reveals Key Insights on Integrated Treatment Apps

CHAPEL HILL, N.C., May. 07, 2025/ --In the rapidly advancing healthcare space, leveraging connected healthcare applications is becoming essential for biopharma and medical device organizations to enhance device functionality and collect valuable treatment data. Best Practices, LLC has released a benchmarking study titled "Connected Health Excellence: Assessing the Development, Deployment, and Impact of Integrated Treatment Apps," which provides in-depth insights into the factors that contribute to the success of connected healthcare applications. Drawing on data from 29 leaders across 26 life sciences organizations, the report offers actionable strategies to optimize the development, deployment, and impact of connected health apps.

According to the study:

• Half of medical device companies report an average investment of $500,000 to $1.5 million for developing, deploying, and maintaining a single connected app.
• The top-ranked drivers of a connected app strategy are improving efficacy and health outcomes, enhancing patient adherence and compliance with treatment, and improving competitive performance in the market.
• Around 77% of respondents rely on different external partners tailored to each connected app.

• Effective strategies for developing connected healthcare applications
• Investment and ROI of connected health apps
• Data collection models and regulatory trends
• Best practices for partnerships and product development
• Impact on patient engagement, adherence, and outcomes

For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw446.htm

Pressed for time? Watch the short video summary below to uncover the key findings and recommendations from the study: